Fortis Healthcare reported a strong financial performance for the fourth quarter and full year ended March 31, 2026, led by sustained growth in its hospital business, improving operating margins, and continued investments in expansion and medical technology.

For Q4 FY26, the company posted consolidated revenues of Rs. 2,365 crore, marking a 17.8% year-on-year increase compared to Rs. 2,007 crore in Q4 FY25. 

Operating EBITDA rose 22.2% to Rs. 531 crore, while EBITDA margins improved to 22.5% from 21.7% in the corresponding quarter last year. 

Profit after tax stood at Rs. 271 crore, registering a sharp 44.2% growth over Rs. 188 crore reported in Q4 FY25.

For the full financial year FY26, consolidated revenues increased 17.3% to Rs. 9,128 crore from Rs. 7,783 crore in FY25. Operating EBITDA climbed 31.3% to Rs. 2,085 crore, with margins expanding to 22.8% compared to 20.4% in the previous year. Profit after tax for FY26 rose 31.5% to Rs. 1,064 crore.

The hospital business remained the primary growth engine, contributing nearly 85% to overall revenues. Hospital segment revenues rose 19% year-on-year to Rs. 2,023 crore in Q4 FY26 and increased 19.1% to Rs. 7,773 crore for the full year. Operating EBITDA from the hospital business grew 28.7% during FY26 to Rs. 1,724 crore.

Growth in the hospital business was driven by a significant increase in occupied beds, which rose 15% during FY26 and 17% in Q4 FY26 compared to the corresponding previous periods. 

International patient revenues also remained strong, increasing 18.5% to Rs. 639 crore during FY26 and contributing 7.8% to hospital revenues.

The diagnostics business under the Agilus brand also delivered healthy growth. Revenues increased 11.1% year-on-year to Rs. 387 crore in Q4 FY26 and rose 8.5% to Rs. 1,527 crore for the full year. 

Dr Ashutosh Raghuvanshi, MD and CEO of Fortis Healthcare, said the company witnessed steady business performance in Q4, enabling it to end the year on a healthy note. He added that the company continued to invest in medical equipment, technology, clinical depth, and expansion of key medical programs.